More recently, studies have challenged the beneficial role of HO-1 in TB disease, reporting that pharmacological inhibition of HO-1 in mice leads to a decrease in Mtb burden (Costa et al., 2016, Scharn et al., 2016). The gene discussed is HMOX1; the disease is tuberculosis.